Skip to content
Politically.com Search all
Menu

Final rule 2026-17429

Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I

The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing mitragynine pseudoindoxyl, MGM-15, and MGM-16 in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these three 7-hydroxymitragynine-related substances.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-08-26 10:49:02 UTC.

Source-supplied record

Document details

Document number
2026-17429
Published
Aug 26, 2026
Effective
Aug 26, 2026
Comments close
Not supplied
Federal Register citation
91 FR 54948

Docket identifiers

  • Docket No. DEA-1644

CFR references

  • Title 21, part 1308